While p21 alteration was not found to be responsible for cancer development in certain cancer types, such as ovarian or breast cancer [4,5], there were evidence supporting the reverse scenario in other tumor types such as thyroid or endometrial carcinoma [6,7]. The gene discussed is CDKN1A; the disease is breast carcinoma.